Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 261 followers
Latest posts
Last updated 2 days ago
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira)...
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 15, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of...
Human medicines European public assessment report (EPAR): RotaTeq, rotavirus vaccine, live, Date of authorisation: 26/06/2006, Revision: 38, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): RotaTeq, rotavirus vaccine, live, Date...
Summary of opinion: Amvuttra, 25/04/2025 Positive
2 days ago
Summary of opinion: Amvuttra, 25/04/2025 Positive
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor /...
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 2, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation...